期刊文献+

胆管内超声诊断胆管细胞癌的研究进展 被引量:1

Research progress on intraductal ultrasonography in the diagnosis of cholangiocarcinoma
下载PDF
导出
摘要 对胆管癌尤其早期胆管癌的诊断仍是当前临床诊疗中的难题。传统的US、CT、MRI、MRCP不能确定胆管扩张的病因、病灶的位置或病灶的范围。胆管内超声(IDUS)对胆管癌的诊断具有重要价值,已逐渐被应用于对胆管狭窄性疾病的诊断。 The diagnosis of bile duct carcinoma, especially early bile duct carcinoma, remains a challenge. Traditional US, CT, MRI, and MRCP can not determine the cause of bile duct expansion, position or range of the lesion. Intraductal ultrasonography (IDUS) is important to the diagnosis of cholangiocarcino- ma, having gradually been applied to the diagnosis of bile duct stricture disease.
出处 《微创医学》 2014年第3期255-259,共5页 Journal of Minimally Invasive Medicine
基金 国家自然科学基金(合同号:81260083 31360221)
关键词 胆管内超声 胆管细胞癌 综述 Intraductal ultrasonography Cholangiocarcinoma Review
  • 相关文献

参考文献6

二级参考文献63

  • 1YIN Long-lin SONG Bin XU Juan LI Ying-chun.Hilar cholangiocarcinoma:preoperative evaluation with a three dimensional volumetric interpolated breath-hold examination magnetic resonance imaging sequence[J].Chinese Medical Journal,2007(8):636-642. 被引量:21
  • 2[1]Patel T.Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.Hepatology 2001;33:1353-1357
  • 3[2]Taylor-Robinson SD,Toledano MB,Arora S,Keegan TJ,Hargreaves S,Beck A,Khan SA,Elliott P,Thomas HC.Increase in mortality rates from intrahepatic cholangJocarcinoma in England and Wales 1968-1998.Gut 2001;48:816-820
  • 4[3]Blendis L,Halpern Z.An increasing incidence of cholangiocarcinoma:why? Gastroenterology 2004;127:1008-1009
  • 5[4]Mouzas IA,Dimoulios P,Vlachonikolis IG,Skordilis P,Zoras O,Kouroumalis E.Increasing incidence of cholangiocarcinoma in Crete 1992-2000.Anticancer Res 2002;22:3637-3641
  • 6[5]Bismuth H,Castaing D,Traynor O.Resection or palliation:priority of surgery in the treatment of hilar cancer.World J Surg 1988;12:39-47
  • 7[6]Farley DR,Weaver AL,Nagorney DM."Natural history"of unresected cholangiocarcinoma:patient outcome after noncurative intervention.Mayo Clin Proc 1995;70:425-429
  • 8[7]Weber A,Landrock S,Schneider J,Stangl M,Neu B,Born P,Classen M,Rosch T,Schmid RM,Prinz C.Long-term outcome and prognostic factors of patients with hilar cholanglocarcinoma.World J Gastroentero12007;13:1422-1426
  • 9[8]Gerhardt T,Milz S,Schepke M,Feldmann G,Wolff M,Sauerbruch T,Dumoulin FL.C-reactive protein is a prognostic indicator in patients with perihilar cholanglocarcinoma.World J Gastroentero12006;12:5495-5500
  • 10[9]Khan SA,Thomas HC,Davidson BR,Taylor-Robinson SD.Cholangiocarcinoma.Lancet 2005;366:1303-1314

共引文献98

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部